These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21316835)

  • 41. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assay to detect H5N1 oseltamivir resistance.
    Suwannakarn K; Chutinimitkul S; Payungporn S; Chieochansin T; Theamboonlers A; Amonsin A; Damrongwatanapokin S; Mai le Q; Hanh NH; Poovorawan Y
    Emerg Infect Dis; 2006 Dec; 12(12):1995-6. PubMed ID: 17354342
    [No Abstract]   [Full Text] [Related]  

  • 44. Structural biology: antiviral drugs fit for a purpose.
    Luo M
    Nature; 2006 Sep; 443(7107):37-8. PubMed ID: 16915238
    [No Abstract]   [Full Text] [Related]  

  • 45. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance.
    Ottmann M; Duchamp MB; Casalegno JS; Frobert E; Moulès V; Ferraris O; Valette M; Escuret V; Lina B
    Antivir Ther; 2010; 15(5):721-6. PubMed ID: 20710053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
    Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
    Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9.
    Aruksakunwong O; Malaisree M; Decha P; Sompornpisut P; Parasuk V; Pianwanit S; Hannongbua S
    Biophys J; 2007 Feb; 92(3):798-807. PubMed ID: 17085491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
    Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI
    J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW; Jo WH
    Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.
    Russell RJ; Haire LF; Stevens DJ; Collins PJ; Lin YP; Blackburn GM; Hay AJ; Gamblin SJ; Skehel JJ
    Nature; 2006 Sep; 443(7107):45-9. PubMed ID: 16915235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
    Govorkova EA; Ilyushina NA; Marathe BM; McClaren JL; Webster RG
    Influenza Other Respir Viruses; 2011 May; 5(Suppl 1):90-3. PubMed ID: 21751467
    [No Abstract]   [Full Text] [Related]  

  • 53. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
    Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
    Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
    Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
    Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.
    Gema LR; Tolentino-Lopez LE; Martínez-Ramos F; Padilla-Martínez I; García-Machorro J; Correa-Basurto J
    J Mol Model; 2015 Jan; 21(1):8. PubMed ID: 25605596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of Tamiflu sensitivity to variants of A/H5N1 virus using different force fields.
    Nguyen TT; Mai BK; Li MS
    J Chem Inf Model; 2011 Sep; 51(9):2266-76. PubMed ID: 21834591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.
    Longtin J; Patel S; Eshaghi A; Lombos E; Higgins R; Alexander D; Olsha R; Doyle J; Tran D; Sarabia A; Lee C; Bastien N; Li Y; Low D; Boivin G; Gubbay J
    J Clin Virol; 2011 Mar; 50(3):257-61. PubMed ID: 21251873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.
    McKimm-Breschkin JL; Barrett S; Pudjiatmoko ; Azhar M; Wong FY; Selleck P; Mohr PG; McGrane J; Kim M
    PLoS One; 2013; 8(6):e66105. PubMed ID: 23776615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.